Comparison of Two Treatment Regimens to Reduce PA Infection in Children With Cystic Fibrosis

NCT00097773 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

304

Enrollment

OTHER

Sponsor class

Conditions

Cystic Fibrosis
Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Tobramycin solution for inhalation (TOBI)
DRUG: Oral placebo
DRUG: Oral ciprofloxacin

Sponsor

Seattle Children's Hospital

Collaborators

[object Object]
[object Object]
[object Object]